Massachusetts Financial Services Co. MA Cuts Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Massachusetts Financial Services Co. MA trimmed its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 8.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 666,201 shares of the company's stock after selling 57,986 shares during the quarter. Massachusetts Financial Services Co. MA owned 1.34% of Prestige Consumer Healthcare worth $57,273,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. CIBC Private Wealth Group LLC increased its position in Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after purchasing an additional 152 shares during the period. Opal Wealth Advisors LLC purchased a new position in Prestige Consumer Healthcare during the 1st quarter valued at $38,000. Headlands Technologies LLC purchased a new position in Prestige Consumer Healthcare during the 4th quarter valued at $40,000. McIlrath & Eck LLC increased its position in Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after purchasing an additional 154 shares during the period. Finally, Johnson Financial Group Inc. purchased a new position in Prestige Consumer Healthcare during the 4th quarter valued at $93,000. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Down 0.2%

Prestige Consumer Healthcare stock traded down $0.13 during mid-day trading on Monday, reaching $75.65. The stock had a trading volume of 425,237 shares, compared to its average volume of 445,391. The company has a market capitalization of $3.74 billion, a price-to-earnings ratio of 16.73, a PEG ratio of 2.27 and a beta of 0.43. The company has a 50-day moving average price of $82.92 and a two-hundred day moving average price of $82.32. Prestige Consumer Healthcare Inc. has a one year low of $64.94 and a one year high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. During the same quarter in the previous year, the business posted $1.02 EPS. Prestige Consumer Healthcare's revenue was up 7.0% compared to the same quarter last year. On average, analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of "Moderate Buy" and a consensus target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.